The CRC specimens with higher TCF12 and MALAT1 gene expressions tended to be CMS-2-subtype tumors only when they also exhibited higher β-catenin gene expression or lower cyclin D1 gene expression (Figure 2E). The gene discussed is MALAT1; the disease is colorectal carcinoma.